RALPH M. RICHART - Corporate Board Profile

INTERNATIONAL ISOTOPES INC

Filing Date	Source Excerpt
2006-05-01	Ralph M. Richart, M.D., age 72, was elected to the Board of Directors on January 22, 2002. The other directors elected him to serve as Chairman on April 24, 2002. Dr. Richart is a professor emeritus in the Department of Pathology at Columbia University College of Physicians and Surgeons. He serves on the Audit and Compensation Committees, chairing the Compensation Committee.
2007-05-22	Ralph M. Richart, M.D., age 73, was elected to the Board of Directors on January 22, 2002. The other directors elected him to serve as Chairman on April 24, 2002. ... The Audit Committee consists of our two non-employee directors, Dr. Richart and Mr. Grosso. ... The Audit Committee held four meetings in 2006. ... The Compensation Committee held one meeting in 2006. ... We do not pay our non-employee directors retainer fees or other fees for service related to the Board or its committees. We reimburse our non-employee directors for their costs associated with attending Board and committee meetings. In 2006, those reimbursements ranged from $1,000 to $2,000. In addition, on August 15, 2006, the Company granted each non-employee director options to purchase shares of the Common Stock under its stockholder-approved 2006 Equity Incentive Plan. The following table provides information on the compensation paid to non-employee directors during fiscal 2006. The Company does not pay Mr. Laflin any compensation in addition to his employee compensation for his Board activities. ... Ralph M. Richart $156,221(2) $156,221 ... (2) At December 31, 2006, Dr. Richart held options to purchase 3,000,000 shares of Common Stock.
2008-04-21	Ralph M. Richart, M.D. was first elected to the Board of Directors in January 2002, and was elected by the Board to serve as Chairman in April 2002. Dr. Richart is professor emeritus in the Department of Pathology at Columbia University College of Physicians and Surgeons, where he was employed from 1963 to 2006 as Vice Chairman. The Audit Committee is comprised of two members, Christopher Grosso and Dr. Ralph Richart. The Compensation Committee held one meeting in 2007. The Company does not pay our non-employee directors retainer fees or other fees for service related to the Board or its committees. We reimburse our non-employee directors for their costs associated with attending Board and committee meetings. In 2007, those reimbursements ranged from $1,000 to $2,000. In addition, on August 15, 2006, the Company granted each non-employee director options to purchase shares of the Common Stock under its stockholder-approved 2006 Equity Incentive Plan. At December 31, 2007, Dr. Richart and Mr. Grosso each held options to purchase 3,000,000 shares of Common Stock, 2,000,000 of which were vested. The Company does not pay Mr. Laflin any compensation in addition to his employee compensation for his Board activities. We did not pay our directors any other compensation in fiscal 2007.
2009-04-30	Ralph M. Richart 75 Professor Emeritus, Columbia University Chairman of the Board We do not pay our non-employee directors retainer fees or other fees for service related to the Board or its committees. We reimburse our non-employee directors for their costs associated with attending Board and committee meetings. In 2008, those reimbursements were $7,119. In addition, on August 15, 2006, the Company granted each non-employee director options to purchase shares of the Common Stock under its stockholder-approved 2006 Equity Incentive Plan. At December 31, 2008, Dr. Richart and Mr. Grosso each held options to purchase 3,000,000 shares of Common Stock, 2,500,000 of which were vested. The Company does not pay Mr. Laflin any compensation in addition to his employee compensation for his Board activities. We did not pay our directors any other compensation in fiscal 2008.
2010-04-29	Ralph M. Richart 76 Professor Emeritus, Columbia University Chairman of the Board ... The Audit Committee is comprised of two members, Christopher Grosso and Mr. Ralph Richart. ... Mr. Richart serves as the Chairman of the Board ... 2009 Director Compensation Table Ralph M. Richart Option Awards: $467,659 Total: $467,659
2010-06-07	Ralph M. Richart was first elected to the Board of Directors in January 2002, and was elected by the Board to serve as Chairman in April 2002. Mr. Richart is professor emeritus in the Department of Pathology at Columbia University College of Physicians and Surgeons, where he was employed from 1963 to 2006. Mr. Richart has previously served on the Board of Directors of several publicly held companies and corporate medical advisory Boards. From 1972 to 2006, he served as Chief Executive Officer of several privately held companies in the fields of medicine and electronics. He has also consulted on clinical trials that resulted in FDA product approval, and he has served as an advisor to medical device and pharmaceutical companies as well as the Food and Drug Administration. Mr. Richart is our largest shareholder. His professional experience gives him unique insights into the Company’s operations, strategic goals, and challenges. The 2009 Director Compensation Table shows he received $467,659 in option awards as compensation. He serves on the Audit Committee and Compensation Committee (Chair).
2011-04-29	Ralph M. Richart Age: 77 Position: Chairman of the Board Committees: Audit Committee (member and Chair), Compensation Committee (member) 2010 Director Compensation Table shows no compensation for Mr. Richart. Excerpt: "Ralph M. Richart 77 Professor Emeritus, Columbia University Chairman of the Board" "Mr. Richart serves as the Chairman of the Board..." "The Audit Committee is comprised of two members, Christopher Grosso and Mr. Ralph Richart..." "Mr. Richart serves as the Chairman of the Board and Mr. Laflin serves as the President, Chief Executive Officer and a director of the Company." "Ralph M. Richart Audit Committee: X* Compensation Committee: X*" "2010 Director Compensation Table Ralph M. Richart Option Awards: - All Other Compensation: - Total: -"
2012-04-30	Mr. Richart serves as the Chairman of the Board and is a member of the Audit Committee and the Compensation Committee. We reimburse our nonemployee directors for their costs associated with attending Board and committee meetings. In 2011, those reimbursements were $2,290 for Mr. Richart.
2013-04-29	Ralph M. Richart, age 79, was first elected to the Board in January 2002, and was elected by the Board to serve as Chairman of the Board in April 2002. Mr. Richart is professor emeritus in the Department of Pathology at Columbia University College of Physicians and Surgeons, where he was employed from 1963 to 2006. Mr. Richart has previously served on the board of directors of several public companies and corporate medical advisory boards. From 1972 to 2006, he served as Chief Executive Officer of several privately held companies in the fields of medicine and electronics. He has also consulted on clinical trials that resulted in FDA product approval, and he has served as an advisor to medical device and pharmaceutical companies as well as the Food and Drug Administration. His experience serving on a number of public company boards provides us with a unique perspective and insight into our operations, strategic goals, and challenges. In addition, Mr. Richart is our longest serving non-employee director and has extensive knowledge of our company and its operations. The Audit Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Grosso serving as the chairman. Mr. Grosso is an "independent director" for audit committee service under NASDAQ Listing Rules. Mr. Richart is not an independent director for audit committee service under NASDAQ Listing Rules because he is an "affiliated person" by virtue of his beneficial ownership of 18.60% of our common stock. The Audit Committee held one meeting in 2012. The Compensation Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Richart serving as the chairman. The Compensation Committee held four meetings in 2012. The following table sets forth information regarding compensation for each of our nonemployee directors for fiscal year 2012. We do not pay our nonemployee directors retainer fees or other fees for service related to the Board or its committees. Equity awards may be granted to the members of the Board from time to time under our 2006 Equity Incentive Plan. In recognition of their significant contributions to our company, in September 2012, each non-employee director was granted an option to purchase 1,000,000 shares of our common stock at an exercise price of $0.17 per share. The options vest in four equal annual installments beginning on the first anniversary of the grant date and the options expire 10 years from the grant date. We also reimburse our non-employee directors for their costs associated with attending Board and committee meetings. In 2012, those reimbursements were $2,290 for Mr. Richart. Steve Laflin does not receive any additional compensation for his service as a director. See "2012 Summary Compensation Table" above for the compensation earned in 2012 by Mr. Laflin for his service as our President and Chief Executive Officer. The following table sets forth information regarding compensation for each of our nonemployee directors for fiscal year 2012. The amounts included under the "Option Awards" column reflect aggregate grant date fair value of the option awards granted in each respective fiscal year, computed in accordance with FASB ASC Topic 718, excluding the effect of any estimated forfeitures. Assumptions used in the calculations of these amounts are included in Note 9 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2012. As of December 31, 2012, the aggregate number of shares underlying outstanding option awards for each nonemployee director was as follows: Mr. Richart - 6,000,000 shares. Pursuant to a Board resolution on September 26, 2012, we re-priced an aggregate of 4,500,000 options of certain of our directors and officers which had an original exercise price of $0.32 per share and expire on May 4, 2019. The options were adjusted to an exercise price of $0.17 per share with the expiration date remaining May 4, 2019. The amount in the table above represents the incremental grant date fair value of the new options over the options originally granted in May 2019.
2014-04-29	Ralph M. Richart, age 80, was first elected to the Board in January 2002, and was elected by the Board to serve as Chairman of the Board in April 2002. ... The Audit Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Grosso serving as the chairman. ... The Compensation Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Richart serving as the chairman. ... 2013 Director Compensation ... Ralph M. Richart ... Option Awards ($) 31,473 ... Total ($) 31,473
2015-04-30	Ralph M. Richart, age 81, has served as a director since January 2002, and was elected by the Board to serve as Chairman of the Board in April 2002. Mr. Richart is professor emeritus in the Department of Pathology at Columbia University College of Physicians and Surgeons, where he was employed from 1963 to 2006. Mr. Richart has previously served on the board of directors of several public companies and corporate medical advisory boards. From 1972 to 2006, he served as Chief Executive Officer of several privately held companies in the fields of medicine and electronics. He has also consulted on clinical trials that resulted in FDA product approval, and he has served as an advisor to medical device and pharmaceutical companies as well as the Food and Drug Administration. Mr. Richart’s experience serving on a number of public company boards provides us with a unique perspective and insight into our operations, strategic goals, and challenges. In addition, Mr. Richart is our longest serving non-employee director and has extensive knowledge of our company and its operations. The Audit Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Grosso serving as the chairman. Mr. Richart is not an independent director for audit committee service under NASDAQ Listing Rules because he is an affiliated person by virtue of his beneficial ownership of 21.0% of our common stock. The Audit Committee is directly responsible for the appointment, compensation, and oversight of our independent registered public accounting firm. The Compensation Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Richart serving as the chairman. The following table sets forth information regarding compensation for each of our nonemployee directors for fiscal year 2014. We do not pay our nonemployee directors retainer fees or other fees for service related to the Board or its committees. Equity awards may be granted to the members of the Board from time to time under our equity compensation plans. We also reimburse our non-employee directors for their costs associated with attending Board and committee meetings. In 2014, those reimbursements were $675 for Mr. Grosso and none for Mr. Richart. Steve Laflin does not receive any additional compensation for his service as a director. See 2014 Summary Compensation Table above for the compensation earned in 2014 by Mr. Laflin for his service as our President and Chief Executive Officer. The following table sets forth information regarding compensation for each of our nonemployee directors for fiscal year 2014. Ralph M. Richart Fees Earned or Paid in Cash ($) - $0, Option Awards ($) - $59,963, All Other Compensation ($) - $0, Total ($) - $59,963.
2016-04-29	Ralph M. Richart, age 82, has served as a director since January 2002, and was elected by the Board to serve as Chairman of the Board in April 2002. Mr. Richart is professor emeritus in the Department of Pathology at Columbia University College of Physicians and Surgeons, where he was employed from 1963 to 2006. Mr. Richart has previously served on the board of directors of several public companies and corporate medical advisory boards. From 1972 to 2006, he served as Chief Executive Officer of several privately held companies in the fields of medicine and electronics. He has also consulted on clinical trials that resulted in FDA product approval, and he has served as an advisor to medical device and pharmaceutical companies as well as the Food and Drug Administration. Mr. Richart’s experience serving on a number of public company boards provides us with a unique perspective and insight into our operations, strategic goals, and challenges. In addition, Mr. Richart is our longest serving non-employee director and has extensive knowledge of our company and its operations. The Audit Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Grosso serving as the chairman. Mr. Richart is not an independent director for audit committee service under NASDAQ listing rules because he is an affiliated person by virtue of his beneficial ownership of 21.13% of our common stock. The Compensation Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Richart serving as the chairman. We do not pay our non-employee directors retainer fees or other fees for service related to the Board or its committees. Equity awards may be granted to the members of the Board from time to time under our equity compensation plans. We also reimburse our non-employee directors for their costs associated with attending Board and committee meetings. In 2015, we did not reimburse Mr. Grosso or Mr. Richart for any expenses in connection with attending any of our Board and committee meetings. We did not grant any equity awards to our non-employee directors during 2015, therefore, our non-employee directors did not receive any director compensation in 2015, as shown in the table below.
2017-05-01	Ralph M. Richart, age 83, has served as a director since January 2002, and was elected by the Board to serve as Chairman of the Board in April 2002. Mr. Richart is professor emeritus in the Department of Pathology at Columbia University College of Physicians and Surgeons, where he was employed from 1963 to 2006. Mr. Richart has previously served on the board of directors of several public companies and corporate medical advisory boards. From 1972 to 2006, he served as Chief Executive Officer of several privately held companies in the fields of medicine and electronics. He has also consulted on clinical trials that resulted in FDA product approval, and he has served as an advisor to medical device and pharmaceutical companies as well as the Food and Drug Administration. Mr. Richart’s experience serving on a number of public company boards provides us with a unique perspective and insight into our operations, strategic goals, and challenges. In addition, Mr. Richart is our longest serving non-employee director and has extensive knowledge of our company and its operations. The Audit Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Grosso serving as the chairman. Mr. Richart is not an independent director for audit committee service under NASDAQ listing rules because he is an affiliated person by virtue of his beneficial ownership of 23.7% of our common stock. The Compensation Committee is comprised of two members, Christopher Grosso and Ralph Richart, with Mr. Richart serving as the chairman. We do not pay our non-employee directors retainer fees or other fees for service related to the Board or its committees. Equity awards may be granted to the members of the Board from time to time under our equity compensation plans. We also reimburse our non-employee directors for their costs associated with attending Board and committee meetings. In 2016, we did not reimburse Mr. Grosso or Mr. Richart for any expenses in connection with attending any of our Board and committee meetings. We did not grant any equity awards to our non-employee directors during 2016, therefore, our non-employee directors did not receive any director compensation in 2016, as shown in the table below.